SAA: Adherence to Antipsychotics for Individuals with Schizophrenia (ACS-19)
Current Value
78.6%
Definition
Line
Bar
Notes on Methodology
- The annual reported rate captures activity during the previous calendar year.
- This is a Healthcare Effectiveness & Data Information Set (HEDIS) administrative measure.
- As of 2014, DVHA’s rates only include only Medicaid Primary beneficiaries in HEDIS administrative measures.
- The target trend line is the 50th percentile national benchmark for Medicaid programs.
Story Behind the Curve
This measure assesses the percentage of members with schizophrenia who were 19-64 years of age during the measurement year and were dispensed and remained on antipsychotic medication for at least 80% of the treatment period.
For people with schizophrenia, nonadherence to treatment with antipsychotics is common, and medication nonadherence is a significant cause of relapse. Measuring antipsychotic medication adherence may lead to less relapse and fewer hospitalizations. Additionally, there is potential to lead to interventions to improve adherence and help close the gap in care between people with schizophrenia and the general population.
Last updated: February 2020